Publications

Li Z, Ma R, Tang H, Guo J, Shah Z, Zhang J, Liu N, Cao S, Marcucci G, Artis D et al..  2024.  Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death.. Cell. 187(3):624-641.e23.

Feng X, Andersson T, Gschwend J, Flüchter P, Berest I, Muff JL, Carchidi D, Lechner A, de Tenorio JC, Brander N et al..  2024.  Tuft cell IL-17RB restrains IL-25 bioavailability and reveals context-dependent ILC2 hypoproliferation.. bioRxiv.

Kabata H, Flamar A-L, Mahlakõiv T, Moriyama S, Rodewald H-R, Ziegler SF, Artis D.  2020.  Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation.. Mucosal Immunol.

Howitt MR, Lavoie S, Michaud M, Blum AM, Tran SV, Weinstock JV, Gallini CAnn, Redding K, Margolskee RF, Osborne LC et al..  2016.  Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut.. Science. 351(6279):1329-33.

Nice TJ, Osborne LC, Tomov VT, Artis D, E Wherry J, Virgin HW.  2016.  Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity.. PLoS Pathog. 12(6):e1005684.